O’Melveny represented Viva Biotech on the listing Viva Biotech (1873.HK) executed its $194 million initial public offering and listing on the Main Board of the Hong…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Michael Patrini
…
This content is for Standard 1 Year members only. LoginJoin Now